Anti-pneumocystis therapy

Anti-pneumocystis therapy involves medications used to treat or prevent Pneumocystis pneumonia (PCP), a lung infection caused by the fungus Pneumocystis jirovecii. Typically, drugs like trimethoprim-sulfamethoxazole are used, which target the fungus effectively. For those unable to tolerate this medication, alternatives like pentamidine or atovaquone may be prescribed. These treatments help eliminate the infection, especially in immunocompromised individuals such as those with HIV/AIDS. The goal is to control the infection, reduce symptoms, and prevent serious lung complications.